Shanghai Junshi Biosciences (SHJBF) News Today C$4.23 0.00 (0.00%) As of 10/10/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock SHJBF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Junshi Biosciences Chairman Plans Significant Shareholding IncreaseOctober 10, 2025 | tipranks.comShanghai Junshi Biosciences Announces Key Board ChangesOctober 1, 2025 | msn.comShanghai Junshi Biosciences Announces Strategic Capital Increase AgreementOctober 1, 2025 | msn.comShanghai Junshi Biosciences Adjusts 2025 A Share Option Incentive SchemeSeptember 29, 2025 | tipranks.comShanghai Junshi Biosciences Passes Key Resolutions at 2025 EGMSeptember 29, 2025 | tipranks.comIs Junshi Biosciences an Opportunity After Its 230% Rally Into 2025?September 15, 2025 | finance.yahoo.comShanghai Junshi Biosciences Adjourns 2025 EGM to Discuss H Share OptionsSeptember 15, 2025 | tipranks.comShanghai Junshi Biosciences Reschedules Extraordinary General MeetingSeptember 15, 2025 | tipranks.comJunshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary EndpointsSeptember 7, 2025 | globenewswire.comShanghai Junshi Biosciences Proposes New Share Option Incentive Schemes for 2025September 2, 2025 | tipranks.comTREOS Bio Partners with Charité Berlin and Junshi Biosciences to Launch Pivotal Phase II Clinical Trial in Refractory MSS Colorectal CancerAugust 27, 2025 | globenewswire.comShanghai Junshi Biosciences Announces Capital Increase and Governance RestructuringAugust 26, 2025 | msn.comJunshi Biosciences Announces 2025 Interim Financial Results and Provides Corporate UpdatesAugust 26, 2025 | globenewswire.comShanghai Junshi Biosciences Sets Terms for Remuneration CommitteeAugust 26, 2025 | msn.comShanghai Junshi Biosciences Reports on 2025 Financial ProceedsAugust 26, 2025 | tipranks.comShanghai Junshi Biosciences Schedules Board Meeting for Interim Results ReviewAugust 14, 2025 | tipranks.comSHJBF Shanghai Junshi Biosciences Co., Ltd. - Seeking AlphaJuly 9, 2025 | seekingalpha.comShanghai Junshi Biosciences Successfully Concludes 2024 AGM with All Resolutions PassedJune 20, 2025 | tipranks.comShanghai Junshi Biosciences Completes Significant H Share PlacementJune 20, 2025 | tipranks.comShanghai Junshi Biosciences Completes HK$1,026 Million H Share PlacementJune 20, 2025 | tipranks.comShanghai Junshi Biosciences Adjusts AGM Book Closure DatesJune 19, 2025 | tipranks.comShanghai Junshi Biosciences Advances Monkeypox Vaccine DevelopmentJune 11, 2025 | tipranks.comShanghai Junshi Biosciences Gains Approval for Innovative Cholesterol-Lowering DrugMay 27, 2025 | tipranks.comShanghai Junshi Biosciences Reports Q1 2025 Financial ResultsApril 25, 2025 | tipranks.comShanghai Junshi Biosciences Appoints New Securities Affairs RepresentativeApril 25, 2025 | tipranks.comShanghai Junshi Biosciences Chairman to Boost Shareholding Amid New AgreementsApril 11, 2025 | tipranks.comShanghai Junshi Biosciences Schedules Board Meeting for Q1 Financial ReviewApril 10, 2025 | tipranks.comShanghai Junshi Biosciences Gains Approval for Toripalimab in SingaporeMarch 26, 2025 | tipranks.comJunshi Biosciences Gains Approval for New HCC TreatmentMarch 21, 2025 | tipranks.comShanghai Junshi Biosciences Gains Approval for Clinical Trials of JS212March 20, 2025 | tipranks.comShanghai Junshi Biosciences Announces Upcoming Board Meeting for Year-End ResultsMarch 15, 2025 | msn.comShanghai Junshi Biosciences Receives Approval for Clinical Trials of Innovative Cancer TherapyFebruary 5, 2025 | tipranks.comJunshi partners LEO Pharma for toripalimab distribution in EuropeJanuary 22, 2025 | msn.comShanghai Junshi Biosciences Partners with LEO Pharma for European ExpansionJanuary 20, 2025 | tipranks.comShanghai Junshi’s Toripalimab Gains TGA Approval for NPC TreatmentJanuary 17, 2025 | tipranks.comShanghai Junshi Biosciences Sees Revenue Growth Amid Reduced Losses in 2024January 17, 2025 | tipranks.comShanghai Junshi Biosciences Receives Regular Approval for COVID-19 DrugJanuary 10, 2025 | tipranks.comShanghai Junshi’s JS212 Drug Application Accepted, Boosting Cancer Therapy PipelineJanuary 8, 2025 | tipranks.comJunshi Biosciences’ Toripalimab Gains Regular Approval for Melanoma TreatmentJanuary 6, 2025 | tipranks.comShanghai Junshi Biosciences Proposes New Board MembersNovember 29, 2024 | tipranks.comShanghai Junshi Unveils Strategic Financial DecisionsNovember 29, 2024 | tipranks.comShanghai Junshi Biosciences Relocates Key OfficesNovember 29, 2024 | tipranks.comShanghai Junshi Biosciences’ TUOYI Gains Key Insurance InclusionNovember 28, 2024 | tipranks.comShanghai A Share IndexNovember 6, 2024 | marketwatch.comJunshi Biosciences Announces Toripalimab Obtained Approval for Marketing in India and China’s Hong Kong SAROctober 16, 2024 | markets.businessinsider.comJunshi Biosciences Announces Toripalimab Obtained Approval for Marketing in India and China's Hong Kong SAROctober 15, 2024 | tmcnet.comJunshi Biosciences Announces Positive Opinion from the European Medicines Agency’s CHMP For ToripalimabJuly 27, 2024 | markets.businessinsider.comWatch: Explore ShanghaiJuly 25, 2024 | bbc.co.ukShanghai Junshi Biosciences Co. Ltd.April 26, 2024 | wsj.comJunshi Biosciences Announces NDA Acceptance in Hong Kong for ToripalimabApril 24, 2024 | finance.yahoo.com Get Shanghai Junshi Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SHJBF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SHJBF Media Mentions By Week SHJBF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SHJBF News Sentiment▼0.490.75▲Average Medical News Sentiment SHJBF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SHJBF Articles This Week▼10▲SHJBF Articles Average Week Get the Latest News and Ratings for SHJBF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Shanghai Junshi Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies 60 Degrees Pharmaceuticals News Algernon Pharmaceuticals News ALK-Abelló A/S News Alpha Tau Medical News Ascentage Pharma Group International News Ascletis Pharma News Avacta Group News Awakn Life Sciences News BerGenBio ASA News BriaCell Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SHJBF) was last updated on 10/14/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredWhat if your job didn’t matter — and neither did China’s chip ban?If you’ve been watching the headlines lately…You’ve seen how Nvidia and AMD just got the green light to resume...Timothy Sykes | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredThe Army Just Got a New Drone SupplierA cutting-edge drone developer just secured a U.S. Army deal to supply its Flex FPV Modular Drones and build a...The Tomorrow Investor | SponsoredNvidia CEO shares biggest regret?Earlier this year I predicted that the only reason Elon was in Washington was to push an AI-first agenda. Sinc...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shanghai Junshi Biosciences Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shanghai Junshi Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
